These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
419 related articles for article (PubMed ID: 28634592)
1. Euglycemic Diabetic Ketoacidosis With Prolonged Glucosuria Associated With the Sodium-Glucose Cotransporter-2 Canagliflozin. Kelmenson DA; Burr K; Azhar Y; Reynolds P; Baker CA; Rasouli N J Investig Med High Impact Case Rep; 2017; 5(2):2324709617712736. PubMed ID: 28634592 [TBL] [Abstract][Full Text] [Related]
2. Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitor use: a case report and review of the literature. Diaz-Ramos A; Eilbert W; Marquez D Int J Emerg Med; 2019 Sep; 12(1):27. PubMed ID: 31488052 [TBL] [Abstract][Full Text] [Related]
3. Euglycemic Diabetic Ketoacidosis with Elevated Acetone in a Patient Taking a Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor. Andrews TJ; Cox RD; Parker C; Kolb J J Emerg Med; 2017 Feb; 52(2):223-226. PubMed ID: 27717592 [TBL] [Abstract][Full Text] [Related]
4. A Case of Prolonged Recovery for Post-percutaneous Coronary Intervention (PCI) Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor-Induced Euglycemic Diabetic Ketoacidosis in a 28-Year-Old. Petersen C; Gyabaah F; Sotelo J; Yohanna S; Deoker A Cureus; 2023 Sep; 15(9):e45180. PubMed ID: 37842482 [TBL] [Abstract][Full Text] [Related]
5. Euglycemic Diabetic Ketoacidosis with Persistent Diuresis Treated with Canagliflozin. Adachi J; Inaba Y; Maki C Intern Med; 2017; 56(2):187-190. PubMed ID: 28090050 [TBL] [Abstract][Full Text] [Related]
6. Prolonged Glucosuria With Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors: A Case Report and Review of Literature. Aggarwal A; Jain A; Sachdeva S; Kulairi ZI Cureus; 2020 Nov; 12(11):e11554. PubMed ID: 33365222 [TBL] [Abstract][Full Text] [Related]
7. Euglycemic diabetic ketoacidosis caused by canagliflozin: a case report. Fukuda M; Nabeta M; Muta T; Fukami K; Takasu O Int J Emerg Med; 2020 Jan; 13(1):2. PubMed ID: 31969112 [TBL] [Abstract][Full Text] [Related]
8. A Literature Review of the Therapeutic Perspectives of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor-Induced Euglycemic Diabetic Ketoacidosis. Patel K; Nair A Cureus; 2022 Sep; 14(9):e29652. PubMed ID: 36320965 [TBL] [Abstract][Full Text] [Related]
9. Euglycemic Diabetic Ketoacidosis in a 27 year-old female patient with type-1-Diabetes treated with sodium-glucose cotransporter-2 (SGLT2) inhibitor Canagliflozin. Bader N; Mirza L Pak J Med Sci; 2016; 32(3):786-8. PubMed ID: 27375734 [TBL] [Abstract][Full Text] [Related]
10. Sodium-glucose cotransporter-2 inhibitor-associated euglycemic diabetic ketoacidosis in COVID-19-infected patients: A systematic review of case reports. Khedr A; Hennawi HA; Khan MK; Eissa A; Mir M; Rauf I; Nitesh J; Surani S; Khan SA World J Clin Cases; 2023 Aug; 11(24):5700-5709. PubMed ID: 37727728 [TBL] [Abstract][Full Text] [Related]
12. SGLT2 Inhibitors: A Systematic Review of Diabetic Ketoacidosis and Related Risk Factors in the Primary Literature. Burke KR; Schumacher CA; Harpe SE Pharmacotherapy; 2017 Feb; 37(2):187-194. PubMed ID: 27931088 [TBL] [Abstract][Full Text] [Related]
13. Prolonged Ketosis in a Patient With Euglycemic Diabetic Ketoacidosis Secondary to Dapagliflozin. Pujara S; Ioachimescu A J Investig Med High Impact Case Rep; 2017; 5(2):2324709617710040. PubMed ID: 28589154 [TBL] [Abstract][Full Text] [Related]
14. Sodium-glucose cotransporter-2 (SGLT2) inhibitor-induced euglycemic diabetic ketoacidosis complicating the perioperative management of a patient with type 2 diabetes mellitus (T2DM) and Fournier's gangrene: A case report. Lindsay PJ; Gibson LE; Bittner EA; Berg S; Chang MG Int J Surg Case Rep; 2020; 77():463-466. PubMed ID: 33395826 [TBL] [Abstract][Full Text] [Related]
15. Euglycemic diabetic ketoacidosis following traumatic brain injury. Jang SW; Lee H Am J Emerg Med; 2024 Mar; 77():232.e1-232.e3. PubMed ID: 38216364 [TBL] [Abstract][Full Text] [Related]
16. Canagliflozin-associated diabetic ketoacidosis: a case report. Chai PR; Bonney C; Blohm E; Boyer EW; Babu KM Toxicol Commun; 2017; 1(1):2-5. PubMed ID: 29978156 [TBL] [Abstract][Full Text] [Related]
17. "Normal but Catastrophic" Euglycemic Diabetic Ketoacidosis Precipitated by Sodium-Glucose Cotransporter-2 Inhibitor Use: A Case Report. Sarno MJF; Hernandez DPF; Matulac MO Cureus; 2023 Nov; 15(11):e49236. PubMed ID: 38143642 [TBL] [Abstract][Full Text] [Related]
18. EUGLYCEMIC DIABETIC KETOACIDOSIS AND SEVERE ACUTE KIDNEY INJURY SECONDARY TO OFF LABEL USE OF SODIUM GLUCOSE COTRANSPORTER-2 INHIBITOR IN A TYPE-1 DIABETIC PATIENT. Tahir H; Wani A; Daruwalla V; Daboul N; Sagi J J Ayub Med Coll Abbottabad; 2015; 27(4):923-4. PubMed ID: 27004352 [TBL] [Abstract][Full Text] [Related]
19. Ketosis and diabetic ketoacidosis in response to SGLT2 inhibitors: Basic mechanisms and therapeutic perspectives. Qiu H; Novikov A; Vallon V Diabetes Metab Res Rev; 2017 Jul; 33(5):. PubMed ID: 28099783 [TBL] [Abstract][Full Text] [Related]
20. Sodium-Glucose Cotransporter-2 Inhibitors and Risk of Diabetic Ketoacidosis Among Adults With Type 2 Diabetes: A Systematic Review and Meta-Analysis. Colacci M; Fralick J; Odutayo A; Fralick M Can J Diabetes; 2022 Feb; 46(1):10-15.e2. PubMed ID: 34116926 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]